Pharmafile Logo

Content for all – how to connect with neurodiverse audiences

Discover essential strategies for crafting inclusive and accessible written content tailored for neurodivergent readers.

Group of friends chatting

Most written content is generally designed and presented for a neurotypical audience. This means that for the 1 in 5 people who are neurodivergent,1 engaging with written content can be a daily challenge.

Accessible and inclusive content is vital in creating equity and embracing diversity. The good news is that there are many ways to support neurodivergent individuals to process information being communicated. In this blog, we will explore three ways to support the development of accessible content for neurodivergent readers.

Key strategies for inclusive content

  1. Prioritise the style and appearance of written information

The readability of content begins with choosing the right font and layout.Sans serif fonts like Arial, Verdana, and Calibri are most inclusive for a neurodiverse audience. This is because they make letters look less crowded, which can facilitate understanding and speed of reading.

There are other ways to improve the style and appearance of writing too:2,3

Do and Don't checklist

  1. Use colours that consider sensory processing differences

Colour plays a crucial role in how content is perceived and processed by neurodivergent audiences. It is important to avoid sensory-loaded and highly saturated colours such as red and yellow in designs since they may trigger sensory overload in some readers. Greens, blues, muted pastel and neutral tones are better to choose from because they are less stimulating and evoke feelings of peace and tranquillity.4,5

Muted tone colour swatch

High contrast colours such as white and pure black on printed materials can be dazzling and visually stressful for neurodivergent readers. Instead, a light background with dark grey text can help with readability. The same is true for digital materials, whilst giving the option to switch the interface between light and dark mode or to a specific hue saturation can help enormously.6

  1. Use visuals and graphics to communicate information

Concise writing that avoids metaphors and figurative language as well as visual aids can significantly enhance attention, comprehension and retention for neurodivergent readers.7,8

Visual elements act as cues and bring structure and sequence to writing. Icons and images placed throughout documents can also help to anchor words to the page and help readers navigate through a written resource more efficiently. Icons and images may also help form memories and improve understanding.2

While traditional content often caters to neurotypical audiences, making small adjustments in font choice, colour use, and visual aids can create a more inclusive experience for neurodivergent readers. For more detailed guidelines on creating accessible content, explore resources from the Neurodiversity Design System, Inclusion & Accessibility Labs, and the British Dyslexia Association.

At Cuttsy+Cuttsy, we are committed to making healthcare communications accessible for everyone. Please get in touch if you’d like to find out more about the work we do.

 

References

1.    The Brain Charity (2022). Accessed: September 2024.

2.    British Dyslexia Association (2023). Accessed: September 2024.

3.    Dyslexia Support South (2023). Accessed: September 2024.

4.    Full Fabric (2024). Accessed: September 2024.

5.    Experia (2021). Accessed: September 2024.

6.    Neurodiversity Design System (2024). Accessed: September 2024.

7.    Fighting Talk Communications (2024). Accessed: September 2024.

8.    Bedrock Learning (2022). Accessed: September 2024.

This content was provided by Cuttsy + Cuttsy

Company Details

 Latest Content from  Cuttsy + Cuttsy 

Where translation falls short in practice

Discover why translation alone is not enough in global clinical trials and how expert localisation improves participant understanding, trust and engagement.

Where it all began – why we developed The Experience Gap

Learn how The Experience Gap was developed to help sponsors, CROs and site teams improve clinical trial participation by identifying friction points, enhancing patient experience, and driving better recruitment and…

Cuttsy+Cuttsy launches a practical roadmap to enhance clinical trial participant experience

Cuttsy+Cuttsy has launched The Experience Gap, a practical roadmap designed to help clinical trial teams improve participant engagement, support and retention across the full study journey.

Cuttsy+Cuttsy welcomes three new experts to the team

Cuttsy+Cuttsy is happy to be welcoming three new people to the team this month.

The gap between hype and reality, what patients really say about weight loss drugs

Explore real patient conversations about weight loss drugs, uncovering challenges, support strategies, and the critical need for clear, reliable healthcare communication.

Why patient-centricity depends on site-centricity in clinical trials

Explore why patient-centricity in clinical trials relies on site-centricity, emphasising the need to design trials that empower site teams to better support patients.

From cloudy to clear: visualising complex data privacy information

Discover how clear communication principles can transform complex clinical research topics, as we conclude our Health Literacy series with a practical example on participant data transparency.

UK clinical trial regs are changing — here’s what’s happening

Discover the transformative updates to UK clinical trial regulations, effective from April 2026, and learn how they aim to enhance transparency, participant safety, and trial efficiency.

The invisible influence on trial retention: why caregivers must be part of the plan

Caregivers are vital to clinical trial retention, yet often overlooked—this article highlights their challenges, impact, and how to better support them.

Where it all began: why we wrote ‘The Site Factor’

Discover the story behind ‘The Site Factor’ and how understanding site teams’ experiences can transform clinical trials for participants and researchers alike.